Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jane Li, A. Chong, Jack Green, R. Kelly, C. Baker (2013)
Mycophenolate use in dermatology: A clinical auditAustralasian Journal of Dermatology, 54
N. Teich (2011)
Infliximab anaphylaxis in siblings.Inflammatory bowel diseases, 17 8
R. Martín, Víctor Trillo, S. Ortega, M. Pérez (2016)
[Peristomal pyoderma gangrenosum after rectal adenocarcinoma in the context of colonic and complex perianal Crohn's disease].Gastroenterología y Hepatología, 39
A. Fernandez, A. Velasco, V. Prieto, J. Cañueto, A. Álvarez, Antonio Rodríguez (2008)
Response to Infliximab in Atypical Pyoderma Gangrenosum Associated With Ulcerative ColitisThe American Journal of Gastroenterology, 103
M. Kaur, H. Lewis (2005)
Severe recalcitrant pyoderma gangrenosum treated with infliximabBritish Journal of Dermatology, 153
J. Mooij, D. Rappard, J. Mekkes (2013)
Six patients with pyoderma gangrenosum successfully treated with infliximabInternational Journal of Dermatology, 52
Louise Barnes, A. Lucky, John Bucuvalas, F. Suchy (1986)
Pustular pyoderma gangrenosum associated with ulcerative colitis in childhood. Report of two cases and review of the literature.Journal of the American Academy of Dermatology, 15 4 Pt 1
D. Hewitt, Clare Tait (2007)
Use of infliximab in pyoderma gangrenosumAustralasian Journal of Dermatology, 48
L. Jenne, B. Sauter, P. Thumann, M. Hertl, G. Schuler (2004)
Successful treatment of therapy‐resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody)British Journal of Dermatology, 150
Ari Goldminz, Nina Botto, A. Gottlieb (2012)
Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab.Journal of the American Academy of Dermatology, 67 5
D. Levy, Meggan Banta, R. Kirsner (2005)
Refractory pyoderma gangrenosum peristomal ulcer and sinus tract treated with micronized cadaveric dermis.Journal of the American Academy of Dermatology, 52 6
Han Pei-pe (2015)
Pyoderma gangrenosum associated with inflammatory bowel diseaseJournal of Clinical Dermatology
A. Ormerod, K. Thomas, F. Craig, E. Mitchell, N. Greenlaw, J. Norrie, J. Mason, S. Walton, G. Johnston, H. Williams (2015)
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trialThe BMJ, 350
A. Marzano, I. Ceccherini, M. Gattorno, D. Fanoni, F. Caroli, M. Rusmini, A. Grossi, C. Simone, O. Borghi, P. Meroni, C. Crosti, M. Cugno (2014)
Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Shares Genetic and Cytokine Profiles With Other Autoinflammatory DiseasesMedicine, 93
M. Carlesimo, C. Abruzzese, Alessandra Narcisi, Giovanna Margagnoni, Giulia Zerboni, F. Purchiaroni, Cristiano Pagnini, E. DiGiulio, V. Corleto (2015)
Cutaneous manifestations and gastrointestinal disorders: Report of two emblematic cases.La Clinica terapeutica, 166 4
V. Akhras, R. Sarkany, S. Walsh, N. Hyde, R. Marsden (2009)
Superficial granulomatous pyoderma treated preoperatively with infliximabClinical and Experimental Dermatology, 34
C. Cubero, M. Tudela, J. Maestrojuan, J. Venegas (2012)
Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.Reumatologia clinica, 8 2
A. Krag, P. Gjersøe (2005)
[Treatment with infliximab of peristomal pyoderma gangrenosum in ulcerative colitis].Ugeskrift for laeger, 167 18
Sunita Coelho, M. Amarelo, S. Ryan, Madhuri Reddy, R. Sibbald (2004)
Rheumatoid arthritis‐associated inflammatory leg ulcers: a new treatment for recalcitrant woundsInternational Wound Journal, 1
P. Eaton, J. Callen (2009)
Mycophenolate mofetil as therapy for pyoderma gangrenosum.Archives of dermatology, 145 7
Klaas Vandevyvere, Frank Luyten, P. Verschueren, Rik Lories, S. Segaert, Rene Westhovens (2007)
Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritisClinical Rheumatology, 26
T. Ljung, M. Staun, O. Grove, O. Fausa, M. Vatn, P. Hellström (2002)
Pyoderma Gangrenosum Associated with Crohn Disease: Effect of TNF- α Blockade with InfliximabScandinavian Journal of Gastroenterology, 37
ଝ. Carmen, Carrasco Cubero, M. Mar, Ruiz Tudela, José Javier, Salaberri Maestrojuan, Pérez Venegas (2012)
Pyoderma Gangrenosum Associated With Inflammatory Bowel Disease. Report of Two Cases With Good Response to InfliximabReumatología Clínica, 8
V. Zampeli, U. Lippert, G. Nikolakis, E. Makrantonaki, T. Tzellos, Ulf Krause, C. Zouboulis (2015)
Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.Journal of dermatological case reports, 9 3
DE Freedberg, S. Husain, A. Swaminath (2013)
Education and imaging. Gastrointestinal: severe inflammatory bowel disease-associated pyoderma gangrenosum.Journal of gastroenterology and hepatology, 28 11
A. Neesse, P. Michl, S. Kunsch, V. Ellenrieder, T. Gress, M. Steinkamp (2007)
Simultaneous Onset of Ulcerative Colitis and Disseminated Pyoderma GangrenosumCase Reports in Gastroenterology, 1
MD Hughes, MD Jackson, MD Callen, Louisville Broadway (2000)
Clinical features and treatment of peristomal pyoderma gangrenosum.JAMA, 284 12
Janelle Ricketts, M. Rothe, J. Grant-Kels (2011)
Cutaneous simulants of infectious diseaseInternational Journal of Dermatology, 50
V. Hubbard, A. Friedmann, P. Goldsmith (2005)
Systemic pyoderma gangrenosum responding to infliximab and adalimumabBritish Journal of Dermatology, 152
Aldana Vacas, A. Torre, M. Bollea-Garlatti, F. Warley, R. Galimberti (2017)
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patientsInternational Journal of Dermatology, 56
J. Staub, N. Pfannschmidt, R. Strohal, M. Braun‐Falco, P. Lohse, S. Goerdt, M. Leverkus (2015)
Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsoneJournal of the European Academy of Dermatology and Venereology, 29
I. Pedro, E. Gómez-Moyano, D. López-Carmona, N. Muñoz-Roca, E. Ramón-Garrido, M. Camps-García (2010)
Utilidad del infliximab en pioderma gangrenoso no asociado a enfermedad inflamatoria intestinalRevista Clinica Espanola, 210
A. Vahlquist, L. Håkansson, L. Rönnblom, M. Karawajczyk, A. Fasth, M. Gijn, D. Roos, P. Venge (2015)
Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab.Acta dermato-venereologica, 95 3
M. Colombo (2007)
Improving Transparency in Medical JournalsThe American Journal of Gastroenterology, 102
A. Sartini, M. Bianchini, F. Schepis, L. Marzi, N. Maria, E. Villa (2016)
Complete resolution of non‐necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infectionClinical Case Reports, 4
D. Marks, F. Rahman, M. Novelli, R. Yu, S. McCartney, S. Bloom, A. Segal (2006)
An exuberant inflammatory response to E coli: implications for the pathogenesis of ulcerative colitis and pyoderma gangrenosumGut, 55
E. Dupuis, Misha Zarbafian, J. Asgarpour, L. Parsons, P. Mydlarski (2017)
Plasmablastic-like lymphoma arising within chronic pyoderma gangrenosumJAAD Case Reports, 3
M. Fleisher, J. Marsal, S. Lee, Laura Frado, A. Parian, B. Korelitz, B. Feagan (2018)
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 63
V. Haridas, P. Shetty, Leonard Dsouza, U. Dinesh, K. Haridas, Anil Bargale (2017)
Pyoderma gangrenosum in Sjögren's syndrome and its successful treatment with topical application of etanerceptInternational Journal of Rheumatic Diseases, 20
S. Donmez, O. Pamuk, M. Gedik, Recep Ak, G. Bulut (2014)
A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximabInternational Journal of Rheumatic Diseases, 17
D. Simian, María Quijada, Jaime Lubascher, R. Acuna, R. Quera (2013)
[Treatment of inflammatory bowel disease with infliximab: experience in 25 patients].Revista medica de Chile, 141 9
M. Gade, Frej Studstrup, A. Andersen, O. Hilberg, Carsten Fogh, E. Bendstrup (2015)
Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature.Respiratory medicine, 109 4
Elena Roche, T. Martínez‐Menchón, J. Sánchez-Carazo, V. Oliver, V. Miquel (2008)
[Two cases of eruptive pyoderma gangrenosum associated with cocaine use].Actas dermo-sifiliograficas, 99 9
Jacqueline Greb, A. Gottlieb, Ari Goldminz (2016)
High‐dose ustekinumab for the treatment of severe, recalcitrant pyoderma gangrenosumDermatologic Therapy, 29
(2007)
EurekAlert!: REMICADE becomes first anti-TNF biologic therapy to treat 1 million patients worldwide
V. Velasco-Tamariz, G. Carreño-Tarragona, F. Tous-Romero, E. Cruz, E. Martín-Clavero, R. Rivera‐Díaz (2017)
Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasoneInternational Wound Journal, 14
S. Field, F. Powell, V. Young, L. Barnes (2008)
Pyoderma gangrenosum manifesting as a cavitating lung lesionClinical and Experimental Dermatology, 33
Hamza Bhatti, Nauman Khalid, B. Rao (2012)
Superficial pyoderma gangrenosum treated with infliximab: a case report.Cutis, 90 6
M. Sapienza, Sidney Cohen, A. Dimarino (2004)
Treatment of Pyoderma Gangrenosum with Infliximab in Crohn's DiseaseDigestive Diseases and Sciences, 49
A. Campanati, V. Brisigotti, G. Ganzetti, E. Molinelli, K. Giuliodori, V. Consales, S. Racchini, E. Bendia, A. Offidani (2015)
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literatureJournal of the European Academy of Dermatology and Venereology, 29
R. Guedes, A. Moreira, Nuno Menezes, A. Baptista, P. Varela (2012)
Treatment of thalidomide resistant pyoderma gangrenosum with etenercept.Acta dermatovenerologica Croatica : ADC, 20 3
M. Pichler, L. Larcher, M. Holzer, Gerald Exler, T. Thuile, B. Gatscher, L. Tappeiner, J. Deluca, C. Carriere, V. Nguyen, V. Moosbrugger-Martinz, M. Schmuth, G. Klein, K. Eisendle (2016)
Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: Case series of 15 patients.Journal of the American Academy of Dermatology, 74 4
D. Mimouni, G. Anhalt, D. Kouba, H. Nousari (2003)
Infliximab for peristomal pyoderma gangrenosumBritish Journal of Dermatology, 148
Y. Kashiwado, A. Uchino, T. Ota, S. Nagano (2018)
Intestinal Behçet’s disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoidsModern Rheumatology, 28
P. Rahimi, I. Grosman, Adnan Khdair (2003)
Control of hemorrhage from a gastric Dieulafoy's lesion using argon plasma coagulationAmerican Journal of Gastroenterology, 98
Y. Byeon, J. Lee, Sang Lee, Chol Park, N. Yun, Young Kim, C. Park, M. Kim (2014)
Peritonsillar Involvement in Pyoderma Gangrenosum associated with Ulcerative ColitisIntestinal Research, 12
Masoomeh Khajehnoori, Timothy O'Brien (2016)
A case of surgically treated peristomal pyoderma gangrenosum in a patient with rheumatoid arthritisJournal of Surgical Case Reports, 2016
A. Rispo, R. Scarpa, E. Girolamo, A. Cozzolino, Giuseppe Lembo, M. Atteno, T. Falco, M. Presti, Fabiana Castiglione (2005)
Infliximab in the treatment of extra‐intestinal manifestations of Crohn's diseaseScandinavian Journal of Rheumatology, 34
(2013)
[Treatment of inflammatory bowel disease with infliximab: experience in 25 patients].
Faiza Fakhar, Sehrish Memon, D. Deitz, Richard Abramowitz, D. Alpert (2013)
Refractory postsurgical pyoderma gangrenosum in a patient with Beckwith Wiedemann syndrome: response to multimodal therapyBMJ Case Reports, 2013
M. Fonder, Deborah Cummins, B. Ehst, G. Anhalt, Jon Meyerle (2006)
Adalimumab Therapy for Recalcitrant Pyoderma GangrenosumJournal of Burns and Wounds, 5
D. Youlden, K. Khosrotehrani, A. Green, H. Soyer, M. Kimlin, P. Youl, Joanne Aitken, P. Baade (2016)
Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry‐based follow‐up studyAustralasian Journal of Dermatology, 57
C. Baliu-Piqué, J. Mascaró (2017)
Multifocal and refractory pyoderma gangrenosum: Possible role of cocaine abuseAustralasian Journal of Dermatology, 58
H. Sonbol, S. Duchatelet, S. Miskinyte, B. Bonsang, Alain Hovnanian, Laurent Misery (2018)
PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneityBritish Journal of Dermatology, 178
Zhenwu Lin, J. Hegarty, T. Lin, B. Ostrov, Yunhua Wang, Wei Yu, Ashley Kelly, L. Poritz, W. Koltun (2011)
Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene.Inflammatory bowel diseases, 17 6
M. Romero‐Gomez, D. Sánchez-Muñoz (2002)
Infliximab induces remission of pyoderma gangrenosum.European journal of gastroenterology & hepatology, 14 8
S. Sagami, Y. Ueno, Shinji Tanaka, K. Nagai, R. Hayashi, K. Chayama (2015)
Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions.Internal medicine, 54 17
G. Pitarch, A. Torrijos, L. Mahiques, J. Sánchez-Carazo, J. Fortea (2006)
Systemic absorption of topical tacrolimus in Pyoderma gangrenosum.Acta dermato-venereologica, 86 1
J. Pinard, David Chiang, A. Mostaghimi, S. Granter, J. Merola, E. Barkoudah (2017)
Wounds That Would Not Heal: Pyoderma Gangrenosum.The American journal of medicine, 131 4
J. Laun, Joshua Elston, Michael Harrington, W. Payne (2016)
Severe Bilateral Lower Extremity Pyoderma GangrenosumEplasty, 16
(2012)
Successful infliximab therapy for hidradenitis suppurativa and pyoderma gangrenosum, complicated by development of palmo‐plantar pustular psoriasis: case report and literature review
A. Marzano, A. Ortega‐Loayza, I. Ceccherini, M. Cugno (2018)
LPIN2 gene mutation in a patient with overlapping neutrophilic disease (pyoderma gangrenosum and aseptic abscess syndrome)JAAD Case Reports, 4
Philippa Youl, Philippa Youl, Monika Janda, J. Aitken, J. Aitken, C. Mar, David Whiteman, Peter Baade, Peter Baade (2011)
Body‐site distribution of skin cancer, pre‐malignant and common benign pigmented lesions excised in general practiceBritish Journal of Dermatology, 165
E. Adışen, M. Öztaş, M. Gürer (2008)
Treatment of Idiopathic Pyoderma Gangrenosum with Infliximab: Induction Dosing Regimen or On-Demand Therapy?Dermatology, 216
P. Yeo, K. Tan, Regina Lim, Sim Seng, Jeannie Ong, R. Rajaratnam (2016)
Neutrophilic Dermatoses as a Continuous Spectrum: An Illustrative Case.Annals of the Academy of Medicine, Singapore, 45 12
K. Kridin, A. Cohen, K. Amber (2018)
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-AnalysisAmerican Journal of Clinical Dermatology, 19
M. Kleinpenning, A. Langewouters, P. Kerkhof, R. Greebe (2011)
Severe pyoderma gangrenosum unresponsive to etanercept and adalimumabJournal of Dermatological Treatment, 22
Lisa Yoo, Saleh Elwir, A. Tinsley, Emmanuelle Williams (2013)
A Case Report of a Patient with Crohnʼs Disease Complicated by Pyoderma Gangrenosum Treated with Intravenous Immunoglobulin: 1419The American Journal of Gastroenterology, 108
M. Heffernan, M. Anadkat, David Smith (2007)
Adalimumab treatment for pyoderma gangrenosum.Archives of dermatology, 143 3
N. Pastor, Isabel Betlloch, José Pascual, Mar Blanes, J. Bañuls, J. Silvestre (2006)
Pyoderma gangrenosum treated with anti‐TNF alpha therapy (etanercept)Clinical and Experimental Dermatology, 31
N. Teich, T. Klugmann (2014)
Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis.Journal of Crohn's & colitis, 8 1
E. Lindwall, Shikha Singla, W. Davis, R. Quinet (2015)
Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome.Seminars in arthritis and rheumatism, 45 1
C. Reddick, M. Singh, R. Chalmers (2010)
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.Dermatology online journal, 16 8
F. Chatzinasiou, D. Polymeros, M. Panagiotou, Konstadinos Theodoropoulos, D. Rigopoulos (2016)
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.Acta dermatovenerologica Croatica : ADC, 24 1
A. Román, F. Bermejo, I. Aldanondo, E. Carrera, D. Boixeda, E. Zato (2004)
Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, 96 6
J. Hsiao, R. Antaya, T. Berger, T. Maurer, K. Shinkai, K. Leslie (2010)
Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review.Archives of dermatology, 146 11
T. Ohashi, K. Yasunobu, Toshiyuki Yamamoto (2015)
Peristomal pyoderma gangrenosum: A report of three casesThe Journal of Dermatology, 42
Hyun Lee, K. Jung, Hyeree Kim, Jun Lee, Hyung‐Ok Kim, Y. Park (2014)
Zosteriform transient acantholytic dermatosisThe Journal of Dermatology, 41
I. Uthman, J. El-Sayad, A. Sharara (2005)
Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening testsClinical and Experimental Dermatology, 30
Oran Goldshmid, Zamir Dovorish, T. Zehavi, A. Eisen, Y. Bar-dayan, H. Amital (2011)
Coexistent pyoderma gangrenosum and tibialis anterior myositis as presenting manifestations of Crohn’s disease: case report and review of the literatureRheumatology International, 31
J. Wet, H. Jordaan, Susanna Kannenberg, B. Tod, Brigitte Glanzmann, Willem Visser (2017)
Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.Dermatology online journal, 23 12
I. Ferkolj, A. Hočevar, R. Golouh, M. Voljč (2006)
Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 15 4
T. Hanafusa, H. Azukizawa, N. Umegaki, M. Tani, Y. Yamaguchi, I. Katayama (2011)
Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid‐resistant pyoderma gangrenosum associated with inflammatory bowel diseaseThe Journal of Dermatology, 38
S. Moschella (2007)
Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated casesInternational Journal of Dermatology, 46
S. Drinda, P. Oelzner, Carolina Canet, M. Kaatz, G. Wolf, G. Hein (2006)
Fatal outcome of pyoderma gangrenosum with multiple organ involvement and partially responding to InfliximabCentral European Journal of Medicine, 1
John Hong, Nina Merel, S. Hanauer (2001)
Treatment of pyoderma gangrenosum (PG) complicating Crohn's disease (CD) with infliximabGastroenterology, 120
R. Galimberti, Aldana Vacas, M. Garlatti, A. Torre (2016)
The role of interleukin-1β in pyoderma gangrenosumJAAD Case Reports, 2
C. Reynolds, N. Schofer, E. Zengi̇n, A. Lohse, S. Faiss, D. Schmiedel (2016)
Multiple Abszesse nach SüdamerikakreuzfahrtDer Internist, 57
G. Kouklakis, J. Moschos, G. Leontiadis, S. Kadis, A. Mpoumponaris, E. Molyvas, G. Minopoulos (2005)
Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.Romanian journal of gastroenterology, 14 4
F. Baglieri, G. Scuderi (2010)
THERAPEUTIC HOTLINE: Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case reportDermatologic Therapy, 23
L. Heard, Vanessa Richardson, C. Lewis, L. Davis (2017)
A case of autoinflammatory skin and bone disease flared by a change in osteoporosis managementJAAD Case Reports, 3
Miho Ueda, M. Katoh, H. Tanizaki, M. Tanioka, Y. Matsumura, Y. Miyachi (2012)
Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.Dermatology online journal, 18 1
Yee Tai, R. Kelly (2005)
Pyoderma gangrenosum complicated by herpes simplex virus infectionAustralasian Journal of Dermatology, 46
(2011)
Severe colitis with pyoderma gangrenosum after ipilimumab treatment in a melanoma patient with colostomy‐a therapeutic challenge
F. Rogge, M. Pacifico, N. Kang (2008)
Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept.Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 61 4
F. Argüelles-Arias, L. Castro-Laria, Triana Lobaton, M. Aguas-Peris, M. Rojas‐Feria, M. Acosta, P. Soto-Escribano, M. Calvo-Moya, D. Ginard-Vicens, M. Chaparro-Sanchez, M. Hernández-Durán, B. Castro-Senosiaín, A. Fernández-Villaverde, V. García‐Sánchez, Enrique Domínguez-Muñoz, Á. Caunedo-Álvarez, J. Herrerías-Gutiérrez (2013)
Characteristics and Treatment of Pyoderma Gangrenosum in Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 58
Dhyan Rajan, Julia Greer, Miguel Regueiro, Leonard Baidoo, David Binion, Hans Herfarth, Corey Siegel, Douglas Hartman, Francis Farraye, Ioannis Koutroubakis, Myron Brand, Emmanuelle Williams, Alka Goyal, Raymond Cross (2016)
IBD LIVE Case Series-Case 6.Inflammatory bowel diseases, 22 11
Irune Cariñanos, M. Acosta, E. Doménech (2011)
Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease.Inflammatory bowel diseases, 17 12
N. Alkhouri, V. Hupertz, L. Mahajan (2009)
Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease.Inflammatory bowel diseases, 15 6
I. Castaño-González, J. Vilar-Alejo, J. Fernández-Palacios, G. Carretero-Hernández (2015)
Infliximab como opción terapéutica en pioderma gangrenoso mamario bilateral postquirúrgico refractarioCirugía Plástica Ibero-Latinoamericana, 41
M. Tan, M. Gordon, O. Lebwohl, J. George, M. Lebwohl (2001)
Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.Archives of dermatology, 137 7
(2011)
Novel combination of intravenous immunoglobulin and rituximab in the treatment of recalcitrant pyoderma gangrenosum
G. C, A. E, C. L (2014)
PIODERMA GANGRENOSO GIGANTE DE CURSO FULMINANTE ASOCIADO A ENFERMEDAD INFLAMATORIA INTESTINALRevista Chilena De Cirugia, 66
M. Hasegawa, Y. Nagai, Y. Sogabe, Tomoyasu Hattori, Chizuru Inoue, E. Okada, O. Tago, O. Ishikawa (2013)
Clinical analysis of leg ulcers and gangrene in rheumatoid arthritisThe Journal of Dermatology, 40
L. Hinterberger, Cornelia Müller, T. Vogt, C. Pföhler (2012)
Adalimumab: a Treatment Option for Pyoderma Gangrenosum After Failure of Systemic Standard TherapiesDermatology and Therapy, 2
Nathan Tofteland, T. Shaver (2010)
Clinical efficacy of etanercept for treatment of PAPA syndrome.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 16 5
D. Sheldon, R. Thirlby, R. Kozarek (2001)
Peristomal pyoderma gangrenosum.Journal of the American College of Surgeons, 193 6
A. Kreuter, S. Reich-Schupke, Markus Stücker, P. Altmeyer, T. Gambichler (2008)
Intravenous immunoglobulin for pyoderma gangrenosumBritish Journal of Dermatology, 158
M. English, Hesham Elghannam, T. Zaman (2009)
A CASE OF PYODERMA GANGRENOSUM OF THE LUNGChest, 136
(2017)
PASH syndrome: a disease with genetic heterogeneity
R. Almukhtar, Andrew Armenta, Julie Martin, Brandon Goodwin, B. Vincent, Brenda Lee, Mara Dacso (2018)
Delayed diagnosis of post-surgical pyoderma gangrenosum: A multicenter case series and review of literatureInternational Journal of Surgery Case Reports, 44
I. Lawrance (2004)
INFLIXIMAB IN THE MANAGEMENT OF THE EXTRA‐INTESTINAL MANIFESTATIONS OF CROHN's DISEASEJournal of Gastroenterology and Hepatology, 19
(2011)
A threat to life and limb: a case of sepsis and osteomyelitis in a patient with undiagnosed pyoderma gangrenosum
F. Morena, Leticia Martín, Javier Gisbert, J. Herrera, R. Goiriz (2007)
Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab.Inflammatory bowel diseases, 13 4
L. Poritz, Marjorie Lebo, Anne Bobb, C. Ardell, W. Koltun (2008)
Management of peristomal pyoderma gangrenosum.Journal of the American College of Surgeons, 206 2
Jin-Hyup Lee, I. Chang, H. Lee, M. Im, Y. Seo, Jeung-Hoon Lee, Y. Lee (2017)
Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab InjectionAnnals of Dermatology, 29
S. Rice, P. Woo, E. El-Omar, R. Keenan, A. Ormerod (2013)
Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s DiseaseBMC Research Notes, 6
F. Ermiş, S. Ozdil, F. Akyüz, B. Pınarbaşı, Z. Mungan (2008)
Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.Inflammatory bowel diseases, 14 11
S. Giacco, D. Firinu, M. Lorrai, L. Serusi, R. Meleddu, M. Barca, M. Peralta, P. Manconi (2012)
Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment.Acta dermato-venereologica, 92 4
Molly Pierce, M. Rice, Jane Fellows (2006)
Wet colostomy and peristomal skin breakdown.Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society, 33 5
M. Regueiro, J. Valentine, S. Plevy, M. Fleisher, G. Lichtenstein (2003)
Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel diseaseAmerican Journal of Gastroenterology, 98
Tomoyuki Ito, Naoko Sato, H. Yamazaki, T. Koike, I. Emura, T. Saeki (2013)
A case of aseptic abscesses syndrome treated with corticosteroids and TNF-alpha blockadeModern Rheumatology, 23
R. Martín, Víctor Trillo, S. Ortega, M. Pérez (2016)
[Peristomal pyoderma gangrenosum after rectal adenocarcinoma in the context of colonic and complex perianal Crohn's disease].Gastroenterologia y hepatologia, 39 5
G. Andrisani, L. Guidi, Alfredo Papa, AE Potenza, D. Cervelli, A. Armuzzi (2013)
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.Journal of Crohn's & colitis, 7 5
K. Arivarasan, V. Bhardwaj, S. Sud, S. Sachdeva, A. Puri (2016)
Biologics for the treatment of pyoderma gangrenosum in ulcerative colitisIntestinal Research, 14
R. Saraceno, G. Babino, A. Chiricozzi, A. Zangrilli, S. Chimenti (2015)
PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition.Journal of the American Academy of Dermatology, 72 1
O. Ennis, A. Feroz, BM Stephenson, M. Allison (2001)
Para-ileostomy pyoderma gangrenosumThe Lancet, 358
J. Peña, M. Moreno-Cobo, M. Sánchez-Conde, A. Quintana (2015)
Behçet disease and refractory pyoderma gangrenosum with response to infliximab.Revista clinica espanola, 215 1
F. Kim, Amit Pandya (2012)
The use of etanercept in the treatment of peristomal pyoderma gangrenosumClinical and Experimental Dermatology, 37
Bryan Mogle, R. Seabury, S. Jennings, Gregory Cwikla (2017)
Severe neutrophilic dermatosis following submental deoxycholic acid administrationClinical Toxicology, 55
D. Hill, S. Naim, A. Watts, M. Morgan, C. Bower, A. Toms (2014)
A report of two patients with a history of pyoderma gangrenosum where total knee arthroplasty was performed under prophylactic immunosuppressionEuropean Orthopaedics and Traumatology, 5
T. Brooklyn, M. Dunnill, A. Shetty, J. Bowden, Jason Williams, C. Griffiths, A. Forbes, R. Greenwood, C. Probert (2005)
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trialGut, 55
(2012)
[Pyoderma gangrenosum: a report of 15 cases and review of the literature].
S. Rizvi, N. Mørk, P. Gjersvik (2013)
[A horseshoe-shaped wound on the back].Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 133 21
S. Ratnagobal, Sinha Sn (2013)
Pyoderma gangrenosum: guideline for wound practitioners.Journal of wound care, 22 2
Sasha Geren, F. Kerdel, A. Falabella, R. Kirsner (2003)
Infliximab: A Treatment Option for Ulcerative Pyoderma Gangrenosum, 15
M. Álvarez‐López, I. Burón-Alvarez, C. Villegas-Fernández (2016)
Refractory pyoderma gangrenosum treated with platelet‐rich plasmaJournal of the European Academy of Dermatology and Venereology, 30
D. Kakagia, E. Efremidou, N. Lyratzopoulos, A. Mitrakas, Michael Pitiakoudis, G. Kouklakis (2010)
Crohn's Disease Associated Pyoderma Gangrenosum Treated with AdalimumabBalkan Medical Journal, 2012
Brian Huang, G. Melmed, D. Shih (2012)
Facial ulceration in a patient with Crohn's disease.Gastroenterology, 142 5
P. Groleau, A. Grossberg, A. Gaspari (2015)
Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.Cutis, 95 6
(2014)
Severe Back Pain in a Young Patient with Pyoderma Gangrenosum and Crohn’s Disease Controlled with Anti-tumor Necrosis Factor Therapy: Sterile OsteomyelitisDermatology and Therapy, 4
A. Marzano, D. Fanoni, E. Antiga, P. Quaglino, M. Caproni, C. Crosti, P. Meroni, M. Cugno (2014)
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndromeClinical & Experimental Immunology, 178
A. Novo-Torres, F. Céspedes-Guirao, Nozay Restituyo, E. Lorda-Barraguer (2016)
Management of pyoderma gangrenosum with combination of systemic treatment, vacuum-assisted closure and synthetic dermal substituteEuropean Journal of Plastic Surgery, 39
B. Murphy, G. Morrison, P. Podmore (2015)
Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitisInternational Journal of Colorectal Disease, 30
D. Meyersburg (2015)
Multilokuläres superfizielles Pyoderma gangraenosum oder PAPA-Syndrom – erfolgreiche Therapie mit UstekinumabAktuelle Dermatologie, 41
A. Marzano, Giovanni Damiani, I. Ceccherini, E. Berti, M. Gattorno, M. Cugno (2017)
Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)British Journal of Dermatology, 176
F. Grange, F. Djilali-Bouzina, A. Weiss, A. Polette, J. Guillaume (2002)
Corticosteroid-Resistant Pyoderma gangrenosum Associated with Crohn’s Disease: Rapid Cure with InfliximabDermatology, 205
P. Juillerat, S. Christen-Zäch, F. Troillet, Suzanne Gallot-Lavallée, Renato Pannizzon, P. Michetti (2007)
Infliximab for the Treatment of Disseminated Pyoderma Gangrenosum Associated with Ulcerative ColitisDermatology, 215
I. Kaufman, D. Caspi, D. Yeshurun, I. Dotan, M. Yaron, O. Elkayam (2005)
The effect of infliximab on extraintestinal manifestations of Crohn’s diseaseRheumatology International, 25
David Sheldon, Lynda Sawchuk, R. Kozarek, R. Thirlby (2000)
Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management.Archives of surgery, 135 5
Natalie Sun, Teresa Ro, P. Jolly, C. Sayed (2017)
Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.The Journal of clinical and aesthetic dermatology, 10 9
A. Marzano, A. Tourlaki, E. Alessi, R. Caputo (2008)
Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10‐year history with a recent response to infliximabClinical and Experimental Dermatology, 33
E. Cinotti, B. Labeille, J. Perrot, B. Pallot-Pradès, F. Cambazard (2014)
Certolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritisClinical and Experimental Dermatology, 39
(2016)
Multiple abscesses after a cruise along the Latin American coast
Marc Scherlinger, S. Guillet, M. Doutre, M. Beylot-Barry, A. Pham‐Ledard (2017)
Pyoderma gangrenosum with extensive pulmonary involvementJournal of the European Academy of Dermatology and Venereology, 31
Jamie Walters, S. Glover (2012)
IVIG Treatment for Refractory Pyoderma Gangrenosum in Patients with Inflammatory Bowel Disease: 1265The American Journal of Gastroenterology, 107
E. Disla, Bhasit Quayum, G. Cuppari, Roberto Pancorbo (2004)
Successful use of etanercept in a patient with pyoderma gangrenosum complicating rheumatoid arthritis.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 10 1
S. Georgiou, E. Pasmatzi, A. Monastirli, D. Tsambaos (2006)
Cutaneous Manifestations of Inflammatory Bowel DiseaseHospital chronicles, 1
K. Williamson, N. Nguyen (2012)
A large shin ulcer after minor trauma: please do not debride!Gastroenterology, 143 4
N. Goldberg, A. Vadlamudi, N. Parrish (2015)
Treatment of Refractory Crohn's Disease and Pyoderma Gangrenosum with a Combination Regimen of Rifaximin, Gentamicin and MetronidazoleCase Reports in Gastroenterology, 9
M. Singh, S. Andrew, J. Lear (2004)
Infliximab as a treatment for recalcitrant pyoderma gangrenosumClinical and Experimental Dermatology, 29
B. McAllister, Emmanuelle Williams, Lisa Yoo, A. Tinsley, W. Koltun, C. Ardell, S. Follett, Diane Paskey (2015)
Refractory Peristomal Pyoderma Gangrenosum Successfully Treated With Intravenous Immunoglobulin: A Case ReportThe American Journal of Gastroenterology, 110
V. Bruzzese (2012)
Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 18 8
A. Cocco, E. Angelucci, A. Viscido, R. Caprilli (2007)
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.Inflammatory bowel diseases, 13 10
P. Koduru, M. Irani, B. Abraham (2017)
Resolution of Pyoderma Gangrenosum With Vedolizumab in a Crohnʼs Patient: 2017 Presidential Poster Award: 1973The American Journal of Gastroenterology, 112
P. Leiphart, Charlene Lam, G. Foulke (2017)
Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridementJAAD Case Reports, 4
M. Tada, T. Nakanishi, Chika Hirata, T. Okano, Y. Sugioka, S. Wakitani, Hiroaki Nakamura, T. Koike (2010)
Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritisModern Rheumatology, 20
G. Goldenberg, J. Jorizzo (2005)
Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitisJournal of Dermatological Treatment, 16
M. Ye, Joshua Ye (2014)
Pyoderma Gangrenosum: A Review of Clinical Features and Outcomes of 23 Cases Requiring Inpatient ManagementDermatology Research and Practice, 2014
J. Triantafillidis, P. Cheracakis, Maria Sklavaina, K. Apostolopoulou (2002)
Favorable Response to Infliximab Treatment in a Patient with Active Crohn Disease and Pyoderma GangrenosumScandinavian Journal of Gastroenterology, 37
M. Shareef, L. Munro, R. Owen, A. Highet (2012)
Progression of IgA gammopathy to myeloma following infliximab treatment for pyoderma gangrenosumClinical and Experimental Dermatology, 37
M. Morete, J. Rodriguez, M. Figueira, A. Echarri (2013)
N015 Patient education on their disease as a determinant on the progression of complications. The role of specialized nursingJournal of Crohn's and Colitis, 7
E. Çalışkan (2017)
Er: YAG Laser Ablation: An Adjuvant Treatment for Medically Resistant Pyoderma Gangrenosum.Dermatologic Surgery
F. Patel, Sarah Fitzmaurice, Christopher Duong, Young He, J. Fergus, S. Raychaudhuri, M. Garcia, E. Maverakis (2015)
Effective strategies for the management of pyoderma gangrenosum: a comprehensive review.Acta dermato-venereologica, 95 5
C. Ahn, D. Negus, W. Huang (2018)
Pyoderma gangrenosum: a review of pathogenesis and treatmentExpert Review of Clinical Immunology, 14
N. Krüger, J. Marchi, M. Souza (2013)
Biological therapy for pyoderma gangrenosumJournal of Coloproctology, 33
E. Zold, A. Nagy, K. Dévényi, M. Zeher, Z. Barta (2009)
Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone.World journal of gastroenterology, 15 18
M. Schwartzfarb, A. Conlan, dPAOLO Romanelli, S. Kirsner (2008)
Pyoderma Gangrenosum in a Patient with Bruton’s X-linked Agammaglobulinemia Shared Pathogenesis of Altered Tumor Necrosis Factor Alpha?
Mio Nakamura, A. Ghaznavi, Vigen Darian, A. Siddiqui (2014)
Pyoderma Gangrenosum Following the Revision of a Breast Reconstruction and AbdominoplastyThe Open Dermatology Journal, 8
H. Hayashi, Chiaki Kuwabara, K. Tarumi, E. Makino, W. Fujimoto (2012)
Successful treatment with infliximab for refractory pyoderma gangrenosum associated with inflammatory bowel diseaseThe Journal of Dermatology, 39
David Roy, E. Conte, D. Cohen (2006)
The treatment of pyoderma gangrenosum using etanercept.Journal of the American Academy of Dermatology, 54 3 Suppl 2
M. Gross, E. Ben-Chetrit (2013)
Laryngeal involvement in Behcet’s disease—a challenge for treatmentClinical Rheumatology, 32
M. Cordero‐Coma, J. Pérez-Moreiras, A. Toribio, N. Alonso-Orcajo, S. Calleja, M. Franco, J. Morales (2012)
Refractory Pyoderma Gangrenosum of the Orbit and the Lacrimal SacOrbit, 31
S. Vural, M. Gundogdu, N. Kundakçı, T. Ruzicka (2017)
Familial Mediterranean fever patients with hidradenitis suppurativaInternational Journal of Dermatology, 56
A. Rispo, A. Testa, M. Diaferia, F. Castiglione, M. Presti (2009)
Monster parastomal pyoderma gangrenosum effectively treated by topical tacrolimus.Journal of Crohn's & colitis, 3 3
Xia Meng, Xinying Zhu, Liping Chen, Jing Wu, Gaifang Liu, B. Xia (2015)
Pyoderma gangrenosum of articulations carpi associated with ulcerative colitis: one case report.International journal of clinical and experimental medicine, 8 10
N. Teich (2014)
Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn’s diseaseTechniques in Coloproctology, 18
F. Wölbing, G. Fierlbeck, W. Hötzenecker, M. Schaller, M. Röcken (2009)
Septic shock after treatment of pyoderma gangrenosum with infliximab.Acta dermato-venereologica, 89 1
S. Jacob, Robyn Weisman, F. Kerdel (2008)
Pyoderma gangrenosum – rebel without a cure?International Journal of Dermatology, 47
D. Kroshinsky, M. Hoang, R. Hasserjian (2012)
Case records of the Massachusetts General Hospital. Case 1-2012. An 82-year-old man with persistent ulcers on the hands.The New England journal of medicine, 366 2
D. Vekic, J. Woods, P. Lin, G. Cains (2018)
SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literatureInternational Journal of Dermatology, 57
G. Duchini, P. Itin, A. Arnold (2011)
A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.Advances in skin & wound care, 24 5
M. Lamiaux, F. Dabouz, M. Wantz, D. Lebas, A. Lasek, D. Courivaud, P. Modiano (2017)
Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndromeJAAD Case Reports, 4
D. Wallach, M. Vignon-Pennamen, A. Marzano, M. Vignon, Pennamen Marzano (2018)
Neutrophilic Dermatoses
E. Mazokopakis, D. Kofteridis, Alexia Pateromihelaki, Sotirios Vytiniotis, Pantelis Karastergiou (2011)
Improvement of ulcerative pyoderma gangrenosum with hyperbaric oxygen therapyDermatologic Therapy, 24
P. Ghazal, K. Herberger, J. Schaller, A. Strölin, N. Hoff, T. Goerge, H. Roth, E. Rabe, S. Karrer, R. Renner, J. Maschke, T. Horn, J. Hepp, S. Eming, U. Wollina, M. Zutt, I. Sick, B. Splieth, D. Dill, J. Klode, J. Dissemond (2013)
Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patientsOrphanet Journal of Rare Diseases, 8
S. Lipka, S. Katz, L. Ginzburg (2013)
Massive pyoderma gangrenosum in a 77 year old female with Crohn's disease responsive to adalimumab.Journal of Crohn's & colitis, 7 5
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementPLoS Medicine, 6
C. Charles, A. Leon, Meggan Banta, R. Kirsner (2007)
Etanercept for the treatment of refractory pyoderma gangrenosum: a brief seriesInternational Journal of Dermatology, 46
C. Hurabielle, P. Schneider, C. Baudry, M. Bagot, M. Allez, M. Viguier (2016)
Certolizumab pegol – A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn’s diseaseJournal of Dermatological Treatment, 27
Jan Kokavec, S. Rajak, S. Huilgol, D. Selva (2016)
Pyoderma gangrenosum of the eyelid.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 51 2
V. Swale, M. Saha, N. Kapur, A. Hoffbrand, M. Rustin (2005)
Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximabClinical and Experimental Dermatology, 30
M. Zaidan, O. Lidove, K. Sacré, I. Klein, T. Papo (2011)
"Fulminant" Behçet disease.Presse medicale, 40 11
C. Beynon, M. Chin, Prasad Hunasehally, K. Bhagwandas, M. Bevan, M. Taylor, T. Lawson (2017)
Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 23 3
K. Shanks, E. Popek, S. Abramson (2006)
Treatment of Pyoderma Gangrenosum (PG) with Infliximab in Leukocyte Adhesion Deficiency (LAD) Type 1The Journal of Allergy and Clinical Immunology, 117
Stanislav Tolkachjov, A. Fahy, D. Wetter, Kevin Brough, A. Bridges, M. Davis, R. El-Azhary, M. McEvoy, M. Camilleri (2015)
Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014.Journal of the American Academy of Dermatology, 73 4
Brittany Buhalog, Kristin Eastman, R. McDonald (2015)
Recalcitrant pyoderma gangrenosum treated with parenteral iron sucrose therapyJAAD Case Reports, 1
S. Kanameishi, S. Nakamizo, Y. Endo, A. Fujisawa, T. Dainichi, T. Tanaka, K. Izawa, R. Nishikomori, K. Kabashima (2017)
High level of serum human interleukin‐18 in a patient with pyogenic arthritis, pyoderma gangrenosum and acne syndromeJournal of the European Academy of Dermatology and Venereology, 31
E. Sinagra, A. Orlando, S. Renna, M. Maida, M. Cottone (2012)
Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.Inflammatory bowel diseases, 18 8
R. Pomerantz, M. Husni, E. Mody, A. Qureshi (2007)
Adalimumab for treatment of pyoderma gangrenosumBritish Journal of Dermatology, 157
H. Jung, S. Chi, Byung Kim, W. Lee, Seok-Jong Lee, Do Kim (2009)
A Case of Recalcitrant Pyoderma Gangrenosum Treated by Infliximab.Journal of Clinical Dermatology, 47
E. Maverakis, Chelsea Ma, K. Shinkai, D. Fiorentino, J. Callen, U. Wollina, A. Marzano, D. Wallach, Kyoungmi Kim, C. Schadt, A. Ormerod, M. Fung, A. Steel, F. Patel, Rosie Qin, F. Craig, H. Williams, F. Powell, A. Merleev, M. Cheng (2018)
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International ExpertsJAMA Dermatology, 154
Julia Stiegler, C. Lucas, N. Sami (2017)
Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisoneJAAD Case Reports, 3
K. Schwaiger, E. Russe, H. Kholosy, M. Hladik, Klemens Heinrich, L. Weitgasser, T. Schoeller, G. Wechselberger (2018)
Reconstructive microsurgical approach for the treatment of pyoderma gangrenosum.Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 71 1
V. Dini, M. Romanelli, M. Bertone, S. Talarico, S. Bombardieri, P. Barachini (2007)
Improvement of Idiopathic Pyoderma Gangrenosum During Treatment With Anti-Tumor Necrosis Factor Alfa Monoclonal AntibodyThe International Journal of Lower Extremity Wounds, 6
(2013)
Refractory pyoderma gangrenosum: utility of combined therapy. Focus on benefits of hyperbaric therapy in its treatment
Parviz Goshtasby, R. Chami, R. Johnson (2010)
A novel approach to the management of pyoderma gangrenosum complicating reduction mammaplasty.Aesthetic surgery journal, 30 2
International Wound Journal – Wiley
Published: Apr 1, 2019
Keywords: ; ; ; ;
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.